Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: Data from a national US cohort

Journal of Viral Hepatitis

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2vnSzLO
via IFTTT